XRCC1

Summary

Gene Symbol: XRCC1
Description: X-ray repair complementing defective repair in Chinese hamster cells 1
Alias: RCC, DNA repair protein XRCC1, X-ray repair cross-complementing protein 1, X-ray-repair, complementing defective, repair in Chinese hamster
Species: human

Top Publications

  1. ncbi DNA repair polymorphisms and cancer risk in non-smokers in a cohort study
    G Matullo
    ISI Foundation and Department of Genetics, Biology and Biochemistry, University of Turin, Turin, Italy
    Carcinogenesis 27:997-1007. 2006
  2. ncbi Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers
    Cheng Yun Yao
    Department of Chemotherapy, Jiangsu Cancer Hospital and Research Institute, Nanjing, China
    Asian Pac J Cancer Prev 10:859-64. 2009
  3. ncbi Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy
    Norman Moullan
    DNA Repair Group, International Agency for Research on Cancer IARC, Lyon, Cedex, France
    Cancer Epidemiol Biomarkers Prev 12:1168-74. 2003
  4. ncbi Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk
    Kim De Ruyck
    Department of Anatomy, Embryology, Histology and Medical Physics, Ghent University, Proeftuinstraat 86, B 9000 Gent, Belgium
    Mutat Res 631:101-10. 2007
  5. ncbi Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans
    Jeffrey S Chang
    Department of Epidemiology and Biostatistics, Division of Neuroepidemiology, University of California San Francisco, San Francisco, CA 94143 1215, USA
    Carcinogenesis 30:78-87. 2009
  6. ncbi Genetic variation in the base excision repair pathway and bladder cancer risk
    Jonine D Figueroa
    Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, Bethesda, MD, USA
    Hum Genet 121:233-42. 2007
  7. ncbi Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients
    Jenny Chang-Claude
    Division of Clinical Epidemiology and Toxicology, German Cancer Research Center, Heidelberg, Germany
    Clin Cancer Res 11:4802-9. 2005
  8. ncbi Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk
    Robert R McWilliams
    Division of Medical Oncology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
    Cancer Res 68:4928-35. 2008
  9. ncbi Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma
    James Doecke
    Queensland Institute of Medical Research, Brisbane, Queensland, Australia
    Int J Cancer 123:174-80. 2008
  10. ncbi Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients
    Xinchen Sun
    Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, China
    Lung Cancer 65:230-6. 2009

Detail Information

Publications239 found, 100 shown here

  1. ncbi DNA repair polymorphisms and cancer risk in non-smokers in a cohort study
    G Matullo
    ISI Foundation and Department of Genetics, Biology and Biochemistry, University of Turin, Turin, Italy
    Carcinogenesis 27:997-1007. 2006
    ..Among the many comparisons, few polymorphisms were associated with the diseases at the univariate analysis: XRCC1-399 Gln/Gln variant homozygotes [odds ratios (OR) = 2.20, 95% confidence intervals (CI) = 1.16-4...
  2. ncbi Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers
    Cheng Yun Yao
    Department of Chemotherapy, Jiangsu Cancer Hospital and Research Institute, Nanjing, China
    Asian Pac J Cancer Prev 10:859-64. 2009
    ..This study was conducted to assess relationships between X-ray repair cross complementing group1 (XRCC1) and xeroderma pigmentosum group D (XPD) genetic polymorphisms and outcome in NSCLC patients.
  3. ncbi Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy
    Norman Moullan
    DNA Repair Group, International Agency for Research on Cancer IARC, Lyon, Cedex, France
    Cancer Epidemiol Biomarkers Prev 12:1168-74. 2003
    The study goal was to examine the association of three polymorphisms in the XRCC1 gene (Arg194Trp, Arg280His, and Arg399Gln) involved in repairing DNA damage produced by ionizing radiation, a known breast cancer (BC) risk factor, with BC ..
  4. ncbi Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk
    Kim De Ruyck
    Department of Anatomy, Embryology, Histology and Medical Physics, Ghent University, Proeftuinstraat 86, B 9000 Gent, Belgium
    Mutat Res 631:101-10. 2007
    ..We investigated the association of 10 base-excision and nucleotide-excision repair gene polymorphisms (XRCC1 -77 T/C, Arg194Trp, Arg280His and Arg399Gln; APE1 Asp148Glu; OGG1 Ser326Cys; XPA -4 G/A; XPC PAT; XPD Asp312Asn ..
  5. ncbi Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans
    Jeffrey S Chang
    Department of Epidemiology and Biostatistics, Division of Neuroepidemiology, University of California San Francisco, San Francisco, CA 94143 1215, USA
    Carcinogenesis 30:78-87. 2009
    ..This study examines the association between 24 single-nucleotide polymorphisms (SNPs) belonging to five BER genes (XRCC1, APEX1, PARP1, MUTYH and OGG1) and lung cancer among Latinos (113 cases and 299 controls) and African-Americans (..
  6. ncbi Genetic variation in the base excision repair pathway and bladder cancer risk
    Jonine D Figueroa
    Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, Bethesda, MD, USA
    Hum Genet 121:233-42. 2007
    ..we analyzed 43 single nucleotide polymorphisms (SNPs) in 12 BER genes (OGG1, MUTYH, APEX1, PARP1, PARP3, PARP4, XRCC1, POLB, POLD1, PCNA, LIG1, and LIG3)...
  7. ncbi Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients
    Jenny Chang-Claude
    Division of Clinical Epidemiology and Toxicology, German Cancer Research Center, Heidelberg, Germany
    Clin Cancer Res 11:4802-9. 2005
    ..We evaluated the association of six polymorphisms in the DNA repair genes: XRCC1 (Arg194Trp, Arg280His, and Arg399Gln), APE1 (Asp148Glu), and XPD (Lys751Gln and Asp312Asn), with the risk of acute ..
  8. ncbi Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk
    Robert R McWilliams
    Division of Medical Oncology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
    Cancer Res 68:4928-35. 2008
    ..Allele and genotype frequencies for 16 SNPs in DNA repair genes ERCC1, XPD/ERCC2, XPC, XPF/ERCC4, OGG1, and XRCC1 were compared after adjusting for age, sex, and smoking history...
  9. ncbi Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma
    James Doecke
    Queensland Institute of Medical Research, Brisbane, Queensland, Australia
    Int J Cancer 123:174-80. 2008
    ..SNPs) (rs12269324, rs12268840, L84F, I143V, K178R), as well as SNPs in DNA repair genes ERCC1 (N118N), XRCC1 (Q399R) and XPD (K751Q). Relative risks were estimated using multivariable logistic regression...
  10. ncbi Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients
    Xinchen Sun
    Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, China
    Lung Cancer 65:230-6. 2009
    ..polymorphisms (SNPs) in Xeroderma pigmentosum group G (XPG) and X-ray repair cross complementing group 1 (XRCC1) were associated with the tumor response in non-small cell lung cancer (NSCLC) patients treated with platinum-..
  11. ncbi A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer
    B Hao
    Department of Biology Sciences and Biotechnology, Tsinghua University, Beijing, China
    Oncogene 25:3613-20. 2006
    X-ray repair cross-complementing 1 (XRCC1) plays a key role in DNA base excision repair and cells lacking its activity are hypersensitive to DNA damage...
  12. ncbi Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling
    Adly Yacoub
    Department of Radiation Oncology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298, USA
    Radiat Res 159:439-52. 2003
    ..importance of radiation-induced and ligand-induced EGFR-ERK signaling for the regulation of DNA repair proteins XRCC1 and ERCC1 in prostate carcinoma cells, DU145 (TP53(mut)), displaying EGFR-TGFA-dependent autocrine growth and high ..
  13. ncbi Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women
    Silvia Sterpone
    Department of Biology, Rome Tre University, Rome, Italy
    J Cancer Res Clin Oncol 136:631-6. 2010
    This study aimed to assess whether haplotypes in XRCC1 and SNPs in OGG1 and XRCC3 were associated with an increased risk of developing breast cancer (BC) and early adverse reactions after radiotherapy.
  14. ncbi X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis
    HuiPing Xue
    Department of Gastroenterology, Renji Hospital, Shanghai Institute of Gastrointestinal Diseases, School of Medicine, Shanghai Jiaotong University, People s Republic of China
    Am J Epidemiol 173:363-75. 2011
    ..performed a systematic review and meta-analysis of associations of the x-ray repair cross-complementing 1 gene (XRCC1) single nucleotide polymorphisms (SNPs) Arg194Trp, Arg280His, and Arg399Gln with gastric cancer risk, based on ..
  15. ncbi Genomic sequence comparison of the human and mouse XRCC1 DNA repair gene regions
    J E Lamerdin
    Human Genome Center, Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, Livermore, California 94550, USA
    Genomics 25:547-54. 1995
    The XRCC1 (X-ray repair cross complementing) gene is involved in the efficient repair of DNA single-strand breaks formed by exposure to ionizing radiation and alkylating agents. The human gene maps to chromosome 19q13...
  16. ncbi Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis
    Yadong Wang
    National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing 100050, PR China
    Cancer Lett 285:134-40. 2009
    ..we assessed reported studies of association between polymorphisms of X-ray repair cross complementing group 1 (XRCC1) codon 399 and 194, and lung cancer risk...
  17. ncbi No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study
    Heather R Ferguson
    Division of Gastroenterology, Belfast City Hospital, Belfast BT9 7AB, Northern Ireland
    Cancer Epidemiol Biomarkers Prev 17:736-9. 2008
    ..polymorphic enzymes, including human 8-oxoguanine glycosylase 1 (hOGG1), X-ray repair cross-complementing 1 (XRCC1), and xeroderma pigmentosum group D (XPD)...
  18. ncbi Polymorphisms of DNA repair genes XRCC1 and XPD and risk of primary open angle glaucoma (POAG)
    Mehmet Guven
    Department of Medical Biology, Cerrahpasa Faculty of Medicine, University of Istanbul, Istanbul, Turkey
    Mol Vis 13:12-7. 2007
    ..enzyme genes, Xeroderma pigmentosum complementation group D (XPD) codon 751 and X-ray cross-complementing group 1 (XRCC1) codon 399, in a sample of Turkish patients with POAG, and to evaluate their association with POAG development.
  19. ncbi Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population
    H Shen
    Department of Epidemiology and Statistics, School of Public Health, Nanjing Medical University, Nanjing, China
    Int J Cancer 88:601-6. 2000
    ..In the present study, we described an association between 2 polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population...
  20. ncbi Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development
    Mustafa Unal
    Department of Ophthalmology, Akdeniz University Medical Faculty, Antalya, Turkey
    Exp Eye Res 85:328-34. 2007
    ..enzyme genes, xeroderma pigmentosum complementation group D (XPD) codon 751 and X-ray cross-complementing group 1 (XRCC1) codon 399, in a sample of Turkish patients with maturity onset cataract...
  21. ncbi Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1
    En Yu Cho
    Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei 10018, Taiwan
    Cancer Epidemiol Biomarkers Prev 12:1100-4. 2003
    ..To evaluate this hypothesis, this study focused on effects of genetic polymorphisms of DNA repair genes hOGG1 and XRCC1 on the development of NPC...
  22. ncbi Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China
    Min Shen
    Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland 20892 7240, USA
    Anticancer Res 25:537-42. 2005
    ..13; 95% CI, 0.96-4.74), whereas persons with the XRCC1 399Gln allele had a decreased risk (OR, 0.60; 95% CI, 0.35-1.02) of lung cancer compared with wild-type carriers...
  23. ncbi Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma
    Bingtao Hao
    Laboratory of Systems Biology, Beijing Institute of Radiation Medicine, Beijing, People s Republic of China
    Cancer Res 64:4378-84. 2004
    ..2 in the coding regions (ADPRT Val762Ala and MBD4 Glu346Lys) and others in noncoding regions (LIG3 A3704G and XRCC1 T-77C), remained as significant predictors for the risk of ESCC. The adjusted odd ratios were 1...
  24. ncbi Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan
    Ching Yu Yen
    Department of Oral and Maxillofacial Surgery, Chi Mei Medical Center, Tainan, and School of Dentistry, Taipei Medical University, Taipei, Taiwan
    J Oral Pathol Med 37:271-7. 2008
    ..In this study, we focused on the joint effect for SNP combinations of four DNA repair genes, X-ray repair cross-complementing groups (XRCCs) 1-4, involved in major cancer-related pathways...
  25. ncbi Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer
    Xifeng Wu
    Department of Epidemiology, Experimental Therapeutics, GI Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 24:3789-98. 2006
    ..Understanding how specific genetic variants modify drug action pathways may provide informative blueprints for individualized chemotherapy...
  26. ncbi Physical and functional interaction between DNA ligase IIIalpha and poly(ADP-Ribose) polymerase 1 in DNA single-strand break repair
    John B Leppard
    Department of Molecular Medicine, Institute of Biotechnology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245, USA
    Mol Cell Biol 23:5919-27. 2003
    ..breaks in mammalian cells is mediated by poly(ADP-ribose) polymerase 1 (PARP-1), DNA ligase IIIalpha, and XRCC1. Since these proteins are not found in lower eukaryotes, this DNA repair pathway plays a unique role in ..
  27. ncbi Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations?
    Peter Aka
    Laboratory for Cell Genetics, Department of Biology, Free University of Brussels, Pleinlaan 2, B 1050 Brussels, Belgium
    Mutat Res 556:169-81. 2004
    ..We have conducted a study to assess the predictivity of the OGG1, XRCC1 and XRCC3 genotypes and the in vitro single strand break repair phenotype for the induction of genotoxic effects...
  28. ncbi Influence of genetic polymorphisms on biomarkers of exposure and genotoxic effects in styrene-exposed workers
    Lode Godderis
    Katholieke Universiteit Leuven, Laboratorium Voor Arbeidshygiëne en Toxicologie, 3000 Leuven, Belgium
    Environ Mol Mutagen 44:293-303. 2004
    ..frequencies of MNMC were found in individuals possessing the XRCC3 Met(241) allele and those individuals with the XRCC1 Gln( (399) ) allele showed higher frequencies of MNMC and MNCB...
  29. ncbi Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
    Shanbeh Zienolddiny
    Department of Toxicology, National Institute of Occupational Health, Oslo, Norway
    Carcinogenesis 27:560-7. 2006
    ..NER) genes XPA, ERCC1, ERCC2/XPD, ERCC4/XPF and ERCC5/XPG; base excision repair (BER) genes APE1/APEX, OGG1, MPG, XRCC1, PCNA, POLB, POLiota, LIG3 and EXO1; double-strand break repair (DSB-R) genes XRCC2, XRCC3, XRCC9, NBS1 and ATR; ..
  30. ncbi XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects
    G Matullo
    Dipartimento di Genetica, Biologia e Biochimica, Universita di Torino, 10126, Torino, ISI Foundation, Institute for Scientific Interchange, Villa Gualino, 10133, Torino, Italy
    Carcinogenesis 22:1437-45. 2001
    ..DNA damage, as measured by (32)P-DNA adduct levels, and three genetic polymorphisms in different repair genes: XRCC1-Arg399Gln (exon 10), XRCC3-Thr241Met (exon 7) and XPD-Lys751Gln (exon 23)...
  31. ncbi A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage
    Sherif F El-Khamisy
    Genome Damage and Stability Centre, University of Sussex, Falmer Brighton BN1 9RQ, UK
    Nucleic Acids Res 31:5526-33. 2003
    ..Here, we show that the single-strand break repair protein XRCC1 is rapidly assembled into discrete nuclear foci after oxidative DNA damage at sites of poly (ADP-ribose) synthesis...
  32. ncbi Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer
    J Chang-Claude
    Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany
    Br J Cancer 100:1680-6. 2009
    ..Polymorphisms in genes involved in DNA repair (APEX1, XRCC1, XRCC2, XRCC3, XPD) and damage response (TP53, P21) were determined...
  33. ncbi Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma
    Feng Yu Chiang
    Department of Otolaryngology Head and Neck Surgery, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan
    Clin Cancer Res 14:5919-24. 2008
    DNA BER pathway is related with carcinogenesis. We hypothesized that functional polymorphisms of three BER genes, XRCC1, apurinic/apyrimidinic endonuclease (APE1), and ADPRT, confer risks for DTC and its progression.
  34. ncbi Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk
    Darren Tse
    Department of Applied Molecular Oncology, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada
    Cancer Causes Control 19:1077-83. 2008
    ..Studies have focused on the nucleotide excision repair (NER) and base excision repair (BER) pathways. We investigated whether variant alleles in seven SNPs within these pathways increased the risk of esophageal adenocarcinoma...
  35. ncbi Joint effects of XRCC1 polymorphisms and polycyclic aromatic hydrocarbons exposure on sperm DNA damage and male infertility
    Guixiang Ji
    Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China
    Toxicol Sci 116:92-8. 2010
    X-ray repair cross-complementing group 1 (XRCC1) plays a role in repairing polycyclic aromatic hydrocarbons (PAHs)-induced DNA damage...
  36. ncbi XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions
    A E Vidal
    Departement de Radiobiologie et Radiopathologie, Commissariat a l Energie Atomique, UMR217 CNRS CEA, BP6, F 92265 Fontenay aux Roses, France
    EMBO J 20:6530-9. 2001
    ..APE1 therefore plays a central role in the base excision repair (BER) pathway. We report here that XRCC1, another essential protein involved in the maintenance of genome stability, physically interacts with APE1 and ..
  37. ncbi XRCC1 codon 280 and ERCC2 codon 751 polymorphisms and risk of esophageal squamous cell carcinoma in a Chinese population
    Xian Dun Zhai
    Institute of Forensic Medicine, Hennan University of Science and Technoogy, Luoyang 471003, Henan, China
    Bull Cancer 96:E61-5. 2009
    ..b>XRCC1 (X-ray cross-complementing group 1) codon 280 and ERCC2 (excision repair cross complementing group 2) codon 751 ..
  38. ncbi Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma
    Zhihua Yin
    Department of Epidemiology, School of Public Health, China Medical University, Shenyang 110001, PR China
    BMC Cancer 9:439. 2009
    ..repair cross-complementing group 1 (ERCC1) and group 2 (ERCC2), and X-ray repair cross-complementing group 1 (XRCC1) proteins play important roles in the repair of DNA damage and adducts...
  39. ncbi CHIP-mediated degradation and DNA damage-dependent stabilization regulate base excision repair proteins
    Jason L Parsons
    Medical Research Council Radiation Oncology and Biology Unit, University of Oxford, Oxfordshire OX1 3QU, UK
    Mol Cell 29:477-87. 2008
    ..The scaffold protein XRCC1, DNA polymerase beta, and DNA ligase IIIalpha play pivotal roles in BER...
  40. ncbi Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1 (XRCC1)
    Giovanni Corso
    Department of Human Pathology and Oncology, Section of General Surgery and Surgical Oncology, Translational Research Laboratory, University of Siena, Siena, Italy
    J Gastrointest Surg 13:2233-8. 2009
    X-ray repair cross complementing group 1 (XRCC1) is one of the major DNA repair proteins involved in the bas-excision repair pathway...
  41. ncbi Genetic polymorphisms of XRCC1 and risk of the esophageal cancer
    J M Lee
    Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
    Int J Cancer 95:240-6. 2001
    ..We hypothesized that the polymorphic XRCC1 genes might modify cancer susceptibility of the esophagus...
  42. ncbi Haplotypes of microsomal epoxide hydrolase and x-ray cross-complementing group 1 genes in Indian hepatocellular carcinoma patients
    Manjula Kiran
    Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India
    DNA Cell Biol 28:573-7. 2009
    ..genetic polymorphism and haplotypes of microsomal epoxide hydrolase (mEPHX) and X-ray cross-complementing group 1 (XRCC1) with altered cancer risk...
  43. ncbi A prospective study of polymorphisms of DNA repair genes XRCC1, XPD23 and APE/ref-1 and risk of stroke in Linxian, China
    Somdat Mahabir
    Department of Epidemiology, CPB4 3247, UT MD Anderson Cancer Center, Unit 1340, 1155 Pressler Blvd, Houston, TX 77030, USA
    J Epidemiol Community Health 61:737-41. 2007
    ..Stroke is the leading cause of death in Linxian, China. Although there is evidence of DNA damage in experimental stroke, no data exist on DNA repair and stroke in human populations...
  44. ncbi [Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma]
    Qian Xi Zhu
    Department of Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China
    Zhonghua Liu Xing Bing Xue Za Zhi 25:702-5. 2004
    To study the association of polymorphisms in the X-ray repair cross-complementing gene 1 (XRCC1) and papillary thyroid carcinoma (PTC).
  45. ncbi Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma
    Lin Cai
    Department of Epidemiology, Fujian Medical University, Fuzhou, Fujian, China
    Cancer 106:2345-54. 2006
    ..To the authors' knowledge, few studies have been conducted to date regarding dietary selenium and the potential gene-nutrient interactions with single-nucleotide polymorphisms (SNPs) in different pathways on the risk of esophageal cancer...
  46. ncbi XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies
    Liping Dai
    Department of Epidemiology and Biostatistics, Zhengzhou University, China
    Int J Cancer 125:1102-9. 2009
    ..Arg194Trp and Arg399Gln in the DNA-base excision repair gene X-ray repair cross-complementing group 1 (XRCC1) have been implicated in risk for esophageal cancer...
  47. ncbi XRCC1 genetic polymorphism and breast cancer risk
    Sook-Un Kim
    Department of Preventive Medicine, Konkuk University College of Medicine, Chungju, Korea
    Pharmacogenetics 12:335-8. 2002
  48. ncbi Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis
    Tang Ho
    Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Thyroid 19:129-35. 2009
    Numerous single-nucleotide polymorphisms (SNPs) of the DNA repair gene XRCC1 have been described. These SNPs have been increasingly studied in the epidemiology of various cancer types...
  49. ncbi A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk
    Alpa V Patel
    Department of Epidemiology and Surveillance Research, American Cancer Society, 1599 Clifton Road NE, Atlanta, GA 30309, USA
    Breast Cancer Res 7:R1168-73. 2005
    The gene XRCC1 (X-ray repair cross-complementing group 1) encodes a protein involved in DNA base excision repair...
  50. ncbi Polymorphisms of DNA repair genes and risk of glioma
    Li E Wang
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Res 64:5560-3. 2004
    ..chromosomal breaks, which may be influenced by genetic variation in genes involved in DNA strand breaks, such as XRCC1 in single-strand break repair, XRCC3 and RAD51 in homologous recombination repair, and XRCC7 in nonhomologous end ..
  51. ncbi Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk
    Hidemi Ito
    Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya Aichi, Japan
    Carcinogenesis 25:1395-401. 2004
    APE1 (apurinic/apyrimidinic endonuclease 1) and XRCC1 (X-ray cross-complementing group 1) are DNA repair proteins that play important roles in the base excision repair (BER) pathway...
  52. ncbi Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial
    Michael S Braun
    Oncology and Clinical Research and Pathology and Tumour Biology Sections, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom
    J Clin Oncol 27:5519-28. 2009
    ..Predicting efficacy and toxicity could potentially allow individualization of cancer therapy. We investigated putative pharmacogenetic markers of chemotherapy toxicity in a large randomized trial. Patients, Materials, and..
  53. ncbi Genetic variation in XRCC1, sun exposure, and risk of skin cancer
    J Han
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, and Harvard Medical School, 181 Longwood Ave, Boston, MA 02115, USA
    Br J Cancer 91:1604-9. 2004
    The XRCC1 gene is involved in the base excision repair pathway...
  54. ncbi Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis
    Wen Yi Huang
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, EPS 8113, MSC 7240, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 14:1747-53. 2005
    ..to common nonsynonymous single-nucleotide polymorphisms in four DNA repair genes: MGMT (Leu84Phe and Ile143Val), XRCC1 (Arg399Gln), XPD (Lys751Gln), and XRCC3 (Thr241Met)...
  55. ncbi The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks
    Joanna I Loizou
    Genome Damage and Stability Centre, University of Sussex, Science Park Road, Falmer, Brighton BN1 9RQ, United Kingdom
    Cell 117:17-28. 2004
    ..We show that this essential protein kinase phosphorylates the scaffold protein XRCC1 and thereby enables the assembly and activity of DNA single-strand break repair protein complexes in vitro and at ..
  56. ncbi Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
    A Ruzzo
    Institute of Biochemistry G Fornaini, University of Urbino, Urbino, Italy
    Pharmacogenomics J 8:278-88. 2008
    ..Risk for Grade III-IV neutropenia was significantly associated with UGT1A1*28 7/7 genotype. These promising findings deserve further investigations and their validation in independent prospective studies...
  57. ncbi An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III
    K W Caldecott
    Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, Livermore, California 94551 0808
    Mol Cell Biol 14:68-76. 1994
    b>XRCC1, the human gene that fully corrects the Chinese hamster ovary DNA repair mutant EM9, encodes a protein involved in the rejoining of DNA single-strand breaks that arise following treatment with alkylating agents or ionizing ..
  58. ncbi DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study
    G Matullo
    Dipartimento di Genetica, Biologia e Biochimica, Universita di Torino, Turin, Italy
    Int J Cancer 92:562-7. 2001
    ..controls (urological and non-urological), 3 DNA polymorphisms localized in 3 genes of different repair pathways (XRCC1-Arg399Gln, exon 10; XRCC3-Thr241Met, exon 7; XPD-Lys751Gln, exon 23) have been analyzed...
  59. ncbi Polymorphisms in the DNA repair gene XRCC1 and age-related disease
    Warren Ladiges
    Comparative Mouse Genomics Center and Department of Comparative Medicine, University of Washington, P O Box 357190, Seattle, WA 98195, USA
    Mech Ageing Dev 124:27-32. 2003
    ..Studies have demonstrated a role for XRCC1 both in vitro and in vivo during the repair of SSB...
  60. ncbi A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer
    J Stoehlmacher
    University of Southern California Norris Comprehensive Cancer Center, Los Angeles 90033, USA
    Anticancer Res 21:3075-9. 2001
    Recently, it has been demonstrated that the Arg399Gln substitution in the XRCC1 gene is associated with increased levels of markers of DNA damage...
  61. ncbi The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy
    Sang Min Yoon
    Department of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea
    Int J Radiat Oncol Biol Phys 63:885-91. 2005
    The X-ray repair cross-complementing Group 1 (XRCC1) protein is involved mainly in the base excision repair of the DNA repair process...
  62. ncbi A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment
    Hao Luo
    Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA
    Mol Cell Biol 24:8356-65. 2004
    ..reaction suggests that the SSBR complex mediated by X-ray repair cross-complementing protein 1 (XRCC1) is assembled sequentially at the site of damage...
  63. ncbi XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies
    Zhibin Hu
    Department of Epidemiology and Biostatistics, Nanjing Medical University School of Public Health, 140 Hanzhong Road, 210029 Nanjing, China
    Cancer Epidemiol Biomarkers Prev 14:1810-8. 2005
    ..Arg194Trp, Arg280His, Arg399Gln) in the DNA base excision repair gene X-ray repair cross-complementing group 1 (XRCC1) have been implicated in cancer risk...
  64. ncbi DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk
    M C Stern
    Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina, 27709, USA
    Cancer Epidemiol Biomarkers Prev 10:125-31. 2001
    ..The XRCC1 gene protein plays an important role in BER by serving as a scaffold for other repair enzymes and by recognizing ..
  65. ncbi Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxa
    Eva Martinez-Balibrea
    Medical Oncology Service, Institut Catala Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona 08916, Barcelona, Spain
    Oncol Rep 17:637-45. 2007
    ..study was to investigate the influence of combining thymidylate synthase (TS), X-ray cross complementing factor 1 (XRCC1) and uridine diphosphate glucoronosyltransferase (UGT1A1 *28) polymorphism genotypes in response rate and time to ..
  66. ncbi Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer
    Eva Martinez-Balibrea
    Medical Oncology Service, Hospital Universitari Germans Trias i Pujol Institut Català d Oncologia, Badalona, Barcelona, Spain
    Eur J Cancer 44:1229-37. 2008
    We studied the role of TS (5'VNTR, 5'SNP and 3'UTR), XRCC1-399, XPD-751, ERCC1-118 and XRCC3-241 genetic polymorphisms in tailoring fluroropyrimidine/oxaliplatin treatment...
  67. ncbi Polymorphisms in the DNA repair gene XRCC1 and breast cancer
    E J Duell
    Department of Epidemiology, School of Public Health, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill 27599 7400, USA
    Cancer Epidemiol Biomarkers Prev 10:217-22. 2001
    X-ray repair cross complementing group 1 (XRCC1) encodes a protein involved in base excision repair...
  68. ncbi Role of a BRCT domain in the interaction of DNA ligase III-alpha with the DNA repair protein XRCC1
    R M Taylor
    School of Biological Sciences, University of Manchester, UK
    Curr Biol 8:877-80. 1998
    ..over 40 other proteins, defining a superfamily that includes DNA ligase III-alpha and the essential human DNA repair protein XRCC1. DNA ligase III-alpha and XRCC1 interact via their carboxyl termini, close to or within regions that ..
  69. ncbi XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis
    Yongsheng Huang
    Institute of Genetics, Fudan University, Shanghai, People s Republic of China
    Mutagenesis 24:331-9. 2009
    X-ray repair cross-complementing group 1 (XRCC1) plays an important role in base excision and single-strand break repair, as a scaffold protein that brings together proteins of the DNA repair complex, and appears to be a candidate for ..
  70. ncbi Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein
    Y Kubota
    Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hertfordshire, UK
    EMBO J 15:6662-70. 1996
    ..The XRCC1 protein, which is known to bind DNA ligase III, is not absolutely required for the reaction but suppresses strand ..
  71. ncbi Influence of DNA repair gene polymorphisms on the yield of chromosomal aberrations
    Anne Kiuru
    Department of Research and Environmental Surveillance, STUK Radiation and Nuclear Safety Authority, FIN 00881 Helsinki, Finland
    Environ Mol Mutagen 46:198-205. 2005
    ..of DNA repair polymorphisms in this variation, genotypes of DNA repair genes OGG1 (codon 326), XPD (codon 751), XRCC1 (X-ray repair cross-complementing group 1) (codons 194, 280, and 399), and XRCC3 (X-ray repair cross-complementing ..
  72. ncbi Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan
    Chih Ching Yeh
    Institute of Environmental Health, National Taiwan University College of Public Health, Taipei 100, Taiwan
    BMC Cancer 5:12. 2005
    ..This study was designed to examine the polymorphisms associated with three DNA repair genes, namely: XRCC1 Arg399Gln, XRCC3 Thr241Met and XPD Lys751Gln, and investigate their role as susceptibility markers for colorectal ..
  73. ncbi Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma
    Alan G Casson
    Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada
    Carcinogenesis 26:1536-41. 2005
    ..extracted from blood samples, we identified wild-type and polymorphic variants of XPD (Arg156Arg and Lys751Gln), XRCC1 (Arg194Trp and Arg399Gln) and XRCC3 (Thr241Met), and the poly (AT) insertion/deletion of XPC (PAT)...
  74. ncbi Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange
    L H Thompson
    Biomedical Sciences Division, Lawrence Livermore National Laboratory, Livermore, California 94550
    Mol Cell Biol 10:6160-71. 1990
    We describe the cloning and function of the human XRCC1 gene, which is the first mammalian gene isolated that affects cellular sensitivity to ionizing radiation...
  75. ncbi XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers
    Mingchuan Li
    Department of Epidemiology, School of Public Health, China Medical University, Shenyang 110001, Liaoning Province, People s Republic of China
    Lung Cancer 62:145-51. 2008
    X-ray repair cross-complementing group 1 (XRCC1) is one of the major DNA repair proteins involved in the base excision repair (BER) and single-strand break repair (SSBR) pathway...
  76. ncbi XRCC1 is phosphorylated by DNA-dependent protein kinase in response to DNA damage
    Nicolas Levy
    Département Intégrité du Génome de l UMR 7175, CNRS, Ecole Superieure de Biotechnologie de Strasbourg, Boulevard S Brant, BP 10413, F 67412 Illkirch cedex, France
    Nucleic Acids Res 34:32-41. 2006
    The two BRCT domains (BRCT1 and BRCT2) of XRCC1 mediate a network of protein-protein interactions with several key factors of the DNA single-strand breaks (SSBs) and base damage repair pathways...
  77. ncbi Roles of DNA ligase III and XRCC1 in regulating the switch between short patch and long patch BER
    Eva Petermann
    Institut fur Biochemie, Freie Universitat Berlin, Thielallee 63, 14195 Berlin, Federal Republic of Germany
    DNA Repair (Amst) 5:544-55. 2006
    ..a reconstituted BER complex containing among others DNA polymerase beta (Pol beta), DNA ligase III (Lig III) and XRCC1, here we show that Lig III and XRCC1 are essential mediators of this regulation...
  78. ncbi DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population
    Sandra Costa
    ICVS, Life and Health Sciences Research Institute, Health Science School, Minho University, Braga, 4710 057, Portugal
    Breast Cancer Res Treat 103:209-17. 2007
    ..We analysed DNA samples from 285 breast cancer patients and 442 control subjects, for XRCC1 Arg399Gln, XPD Lys751Gln, RAD51 G135C and XRCC3 Thr241Met polymorphisms using PCR-RFLP...
  79. ncbi Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy
    Annamaria Ruzzo
    Institute of Biochemistry G Fornaini, University of Urbino, Urbino, Italy
    J Clin Oncol 25:1247-54. 2007
    ....
  80. ncbi DNA damage repair and genetic polymorphisms: assessment of individual sensitivity and repair capacity
    Tommaso Cornetta
    Department of Biology, Universita degli Studi Roma Tre, Rome, Italy
    Int J Radiat Oncol Biol Phys 66:537-45. 2006
    ..To study the repair capacity after X-ray irradiation in human peripheral blood cells of healthy subjects, in relation to their genotypes...
  81. ncbi Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck
    Chunying Li
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 110:867-75. 2007
    ..BER) pathway, in which adenosine diphosphate ribosyl transferase (ADPRT), x-ray repair cross-complementing 1 (XRCC1), and apurinic/apyimidinic endonuclease (APE1) play key roles...
  82. ncbi A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma
    Eric J Duell
    Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Cancer Res 62:4630-6. 2002
    b>XRCC1 (X-ray repair cross-complementing group 1) is a base excision repair protein that plays a central role in the repair of DNA strand breaks and base damage from a variety of endogenous and exogenous oxidants including tobacco smoke...
  83. ncbi Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers
    Yu Chen Lei
    Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, No 1 Ren Ai Road, Sec 1, 10018 Taipei, ROC
    Mutat Res 519:93-101. 2002
    ..microsomal epoxide hydrolase (mEH), glutathione S-transferase M1 (GSTM1), and X-ray cross-complementing group 1 (XRCC1) and cigarette smoking-induced SCE. Sixty-one workers without significant exposure to mutagens were recruited...
  84. ncbi XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking
    Brian F Pachkowski
    Department of Environmental Sciences, School of Public Health, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    Cancer Res 66:2860-8. 2006
    ..DNA damage that necessitates repair by base excision repair coordinated by X-ray cross-complementing gene 1 (XRCC1)...
  85. ncbi Influence of hOGG1, XRCC1 and XRCC3 genotypes on biomarkers of genotoxicity in workers exposed to cobalt or hard metal dusts
    R Mateuca
    Vrije Universiteit Brussel, Laboratorium voor Cellulaire Genetica, Pleinlaan 2, B 1050 Brussels, Belgium
    Toxicol Lett 156:277-88. 2005
    ..We examined whether variations in genes involved in base-excision (hOGG1, XRCC1) and double strand break (XRCC3) DNA repair contribute to inter-individual differences in genotoxic effects ..
  86. ncbi XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population
    Zhonghua Wang
    Department of Medical Oncology, Cancer Hospital of Fudan University, Shanghai Medical College, No 270 Dongan Road, Shanghai 200032, PR China
    Lung Cancer 62:99-104. 2008
    ..The predictability of DNA repair XRCC1 (X-ray repair cross-complementing group 1 protein) single nucleotide polymorphisms (SNPs) for cisplatin-based ..
  87. ncbi XRCC1-DNA polymerase beta interaction is required for efficient base excision repair
    Irina I Dianova
    Radiation and Genome Stability Unit, Medical Research Council, Harwell, Oxfordshire OX11 0RD, UK
    Nucleic Acids Res 32:2550-5. 2004
    X-ray repair cross-complementing protein-1 (XRCC1)-deficient cells are sensitive to DNA damaging agents and have delayed processing of DNA base lesions...
  88. ncbi Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes
    Alice J Sigurdson
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 6120 Executive Boulevard, Bethesda, Maryland, 20892 7238, USA
    BMC Cancer 4:9. 2004
    ..Thus, 19 single nucleotide polymorphisms (SNPs) in eight genes involved in base excision repair (XRCC1, APEX, POLD1), BRCA1 protein interaction (BRIP1, ZNF350, BRCA2), and growth regulation (TGFss1, IGFBP3) were ..
  89. ncbi Genetic polymorphisms and head and neck cancer outcomes: a review
    Jessica Hopkins
    Community Medicine Residency Program and Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada
    Cancer Epidemiol Biomarkers Prev 17:490-9. 2008
    ..Polymorphisms of XRCC1, FGFR, and CCND1 have been consistently associated with HNC survival in at least two studies, whereas most of the ..
  90. ncbi DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population
    Senqing Chen
    Laboratory of Genetics, Jiangsu Institute for Cancer Research, Nanjing 210009, People s Republic of China
    Carcinogenesis 23:1321-5. 2002
    X-ray repair cross-complementing group 1 (XRCC1) and xeroderma pigmentosum group D (XPD) are mainly involved in base excision repair (BER) and nucleotide excision repair (NER) of DNA repair pathways, respectively...
  91. ncbi Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD
    Chun Chi Chiang
    Department of Ophthalmology, China Medical University Hospital, Taichung, Taiwan
    Mol Vis 16:698-704. 2010
    ..NER) systems are the major ones involved in repairing UV-induced DNA damage; X-ray repair cross complementary 1 (XRCC1) and human 8-oxoguanine DNA glycosylase 1 (hOGG1) are two BER genes, and xeroderma pigmentosum group A (XPA) and ..
  92. ncbi Beta-blockers and diuretics: to use or not to use
    F H Messerli
    Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121, USA
    Am J Hypertens 12:157S-163S. 1999
    ..safety and efficacy, the recent findings suggesting that long-term use increased the risk for renal cell carcinoma (RCC) is of concern...
  93. ncbi E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair
    Dexi Chen
    Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health and Science University, 3181 S W Sam Jackson Park Road, Portland, OR 97239, USA
    J Biol Chem 283:15381-9. 2008
    ..b>XRCC1 (x-ray repair cross-complementing group 1) protein is important for efficient single strand break/base excision ..
  94. ncbi Colloid cyst of the third ventricle: a comparative ultrastructural study of neuraxis cysts and choroid plexus epithelium
    B Lach
    Department of Laboratory Medicine, Ottawa Civic Hospital, Ontario, Canada
    Ultrastruct Pathol 16:331-49. 1992
    Thirteen colloid cysts (CC), four Rathke cleft cysts (RCC), three follicular cysts of normal pituitary gland (FCP), four enterogenous cysts (EC), three normal choroid plexi (CP), three choroid plexus papillomas (CPP), and several samples ..
  95. ncbi Renal angiomyolipoma: report of three cases with regional lymph node involvement and/or with renal cell carcinoma
    G Csanaky
    Department of Pathology, , Hungary
    Tumori 81:469-74. 1995
    ..different organ sites such as kidneys, lymph nodes, liver and lung and may be associated with renal cell carcinoma (RCC)...
  96. ncbi Serum levels of cytokines and soluble cytokine receptors in patients with metastatic renal cell carcinoma or malignant melanoma receiving IL-2/interferon-alpha combination therapy
    S D Fossa
    Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo
    Acta Oncol 34:599-603. 1995
    ..and (at a lesser degree) of sTNFR-75 were found in most of the patients with metastatic renal cell carcinoma (RCC) or malignant melanoma (MM) before immunotherapy and with further increase during treatment (intravenous infusions ..
  97. ncbi Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha in renal cell carcinoma. A randomized phase II trial
    F Boccardo
    Department of Medical Oncology II, National Institute for Cancer Research, Genoa, Italy
    Tumori 84:534-9. 1998
    ..IFN), either alone or in combination, in comparable groups of patients affected by advanced renal cell carcinoma (RCC). PATIENTS AND METHODS: In order to limit selection biases, treatment was allocated on a random basis...
  98. ncbi A randomized study of low-dose interleukin-2 subcutaneous immunotherapy versus interleukin-2 plus interferon-alpha as first line therapy for metastatic renal cell carcinoma
    P Lissoni
    Divisione di Radioterapia Oncologica, Ospedale S. Gerardo, Monza (Milano, Italy
    Tumori 79:397-400. 1993
    ..rate comparable to that obtained with IL-2 intravenous injection in patients with metastatic renal cell carcinoma (RCC) but with lower toxicity. The role of IFN when combined with IL-2 has however still to be defined...
  99. ncbi Estramustine-binding protein (EMBP) in renal cell carcinoma immunohistochemistry, immunoscintigraphy and in vitro estramustine effects
    M Edgren
    Department of Oncology, Akademiska sjukhuset, Uppsala University, Sweden
    Acta Oncol 35:483-8. 1996
    The present report shows that the human renal cell carcinoma (RCC) cell lines, A498 and CAKI-2, express the estramustine-binding protein (EMBP)...
  100. ncbi Significance of thymidylate synthase activity in renal cell carcinoma
    Yoichi Mizutani
    Department of Urology, Kyoto Prefectural University of Medicine, Kyoto 602 8566
    Clin Cancer Res 9:1453-60. 2003
    5-Fluorouracil (5-FU) is an anticancer agent clinically used against various cancers including renal cell carcinoma (RCC). 5-FU inhibits thymidylate synthase (TS) and blocks DNA synthesis...
  101. ncbi Vinblastine and interferon-alpha-2a regimen in the treatment of metastatic renal cell carcinoma
    S Palmeri
    Sezione di Oncologia Clinica, Policlinico,
    Tumori 76:64-5. 1990
    Thirteen patients with histologically proven advanced and/or metastatic renal cell carcinoma (RCC) were treated with vinblastine (Velbe, Eli Lilly, Sesto Fiorentino, Italy) and interferon-alpha-2a (Roferon-A, Roche, Milan)...

Research Grants99

  1. Genotype and phenotype predictors in therapy response in renal cell carcinoma
    Katherine L Nathanson; Fiscal Year: 2010
    Therapy of renal cell carcinoma (RCC) has been transformed in recent years by the efficacy of targeted agents that inhibit kinases involved in critical cellular signaling pathways and VEGF, a primary driver of tumor angiogenesis...
  2. Genotype and phenotype predictors in therapy response in renal cell carcinoma
    William Lee; Fiscal Year: 2009
    Therapy of renal cell carcinoma (RCC) has been transformed in recent years by the efficacy of targeted agents that inhibit kinases involved in critical cellular signaling pathways and VEGF, a primary driver of tumor angiogenesis...
  3. Genetic Susceptibility Modifiers in Renal Cell Carcinoma
    Xifeng Wu; Fiscal Year: 2007
    ..Tobacco exposure is an established risk factor for renal cell carcinoma (RCC)...
  4. Regulations of DNA Alkylation/Deamination Damage Repair
    Rabindra Roy; Fiscal Year: 2010
    ..with and can be stimulated by various factors including hHR23A/B (a nucleotide excision repair protein) and XRCC1 (a BER protein)...
  5. Regulations of DNA Alkylation/Deamination Damage Repair
    Rabindra Roy; Fiscal Year: 2009
    ..with and can be stimulated by various factors including hHR23A/B (a nucleotide excision repair protein) and XRCC1 (a BER protein)...
  6. Regulations of DNA Alkylation/Deamination Damage Repair
    Rabindra Roy; Fiscal Year: 2011
    ..with and can be stimulated by various factors including hHR23A/B (a nucleotide excision repair protein) and XRCC1 (a BER protein)...
  7. Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206
    Hyung L Kim; Fiscal Year: 2010
    One third of patients newly diagnosed with renal cell carcinoma (RCC) have metastatic disease...
  8. Clinical Impact of B7-H Immune Cell Coregulators in Renal Cell Carcinoma
    Eugene Kwon; Fiscal Year: 2009
    Renal cell carcinoma (RCC) encompasses 90% of kidney cancers and 3% of adult cancers. In the U.S. alone, more than 30,000 new cases of RCC are diagnosed and nearly 13,000 patients die from RCC annually...
  9. Clinical Impact of B7-H Immune Cell Coregulators in Renal Cell Carcinoma
    EUGENE D contact KWON; Fiscal Year: 2010
    Renal cell carcinoma (RCC) encompasses 90% of kidney cancers and 3% of adult cancers. In the U.S. alone, more than 30,000 new cases of RCC are diagnosed and nearly 13,000 patients die from RCC annually...
  10. Targeting Tumor Angiogenesis with SAHA and Bevacizumab in Kidney Cancer
    Roberto Pili; Fiscal Year: 2007
    ..angiogenesis is critical for the development and progression of epithelial tumors including renal cell carcinoma (RCC)...
  11. REGULATORY PATHWAYS AND ROLE OF VPF/VEGF IN RENAL CANCER
    Debabrata Mukhopadhyay; Fiscal Year: 2009
    Most of the cases, the clear-cell renal cell carcinoma (RCC) express strikingly elevated baseline levels of vascular permeability factor also known as vascular endothelial growth factor (VEGF) rationalized their vascular nature...
  12. REGULATORY PATHWAYS AND ROLE OF VPF/VEGF IN RENAL CANCER
    Debabrata Mukhopadhyay; Fiscal Year: 2010
    Most of the cases, the clear-cell renal cell carcinoma (RCC) express strikingly elevated baseline levels of vascular permeability factor also known as vascular endothelial growth factor (VEGF) rationalized their vascular nature...
  13. Identification of Biomarkers for Early Detection of Renal Cell Carcinoma
    Othon Iliopoulos; Fiscal Year: 2010
    The incidence of renal cell carcinoma (RCC) in United States has been projected to reach 56,000 cases/year in 2007 and has been rising since 1970 for both men and women and for whites as well as blacks...
  14. Analysis of the Novel Kinase ROR2: A New Molecular Target in Renal Cell Carcinoma
    Tricia Wright; Fiscal Year: 2007
    Renal cell carcinoma (RCC), a notoriously hard to treat solid tumor and the most common form of kidney cancer, has minimal sensitivity to traditional chemotherapy...
  15. MOLECULAR-GENETIC ANALYSIS OF 3P14 GENOMIC STABILITY
    Harry Drabkin; Fiscal Year: 2006
    ..of any protein that interacts with VHL and its function may be germane to the development of renal cell carcinoma (RCC)...
  16. TRAIL-expressing Recombinant Adenovirus Based Immunotherapy for RCC
    Thomas S Griffith; Fiscal Year: 2010
    This year in the U.S. ~40,000 new cases of renal cell carcinoma (RCC) will be diagnosed and >13,000 deaths are expected from RCC...
  17. TRAIL-expressing Recombinant Adenovirus Based Immunotherapy for RCC
    THOMAS GRIFFITH; Fiscal Year: 2009
    This year in the U.S. ~40,000 new cases of renal cell carcinoma (RCC) will be diagnosed and >13,000 deaths are expected from RCC...
  18. Genetic Retargeted Human T-cells for RCC Immunotherapy
    Wayne Marasco; Fiscal Year: 2006
    Renal cell carcinoma (RCC) is the most prevalent malignancy within the kidney and the incidence is rising. Due to improved radiological evaluation, over 50% of the renal cancers are found incidentally...
  19. Roles of Lig3 and XRCC1 Genes in Genome Stability
    Alan E Tomkinson; Fiscal Year: 2010
    ..Interestingly, the DNA ligase III?-associated proteins, poly (ADP-ribose) polymerase 1 (PARP-1), XRCC1 and DNA polymerase (Pol) ?, each of which have been implicated in base excision repair and the repair of DNA ..
  20. Allogeneic T Cell Responses Against Renal Cell Carcinoma
    Edus Warren; Fiscal Year: 2007
    Renal cell carcinoma (RCC) is distinguished amongst solid tumors for its resistance to conventional chemo- and radiotherapy but its susceptibility, in a minority of patients, to immunologic manipulation...
  21. Predictive Markers in Metastatic Renal Cancer
    Frederic M Waldman; Fiscal Year: 2010
    Metastatic renal cell carcinoma (RCC) is a dismal disease, with nearly uniform resistance to radiotherapy, chemotherapy and immunotherapy...
  22. Predictive Markers in Metastatic Renal Cancer
    Frederic Waldman; Fiscal Year: 2009
    Metastatic renal cell carcinoma (RCC) is a dismal disease, with nearly uniform resistance to radiotherapy, chemotherapy and immunotherapy...
  23. Recombinant Immunotherapy for Renal Cell Carcinoma
    THOMAS GRIFFITH; Fiscal Year: 2007
    ..This year in the U.S. approximately 30,000 new cases of renal cell carcinoma (RCC) will be diagnosed and nearly 12,000 deaths are expected from RCC...
  24. MDA-7/IL-24 and free radicals in renal cancer therapy
    Paul Dent; Fiscal Year: 2007
    Renal Cell Carcinoma (RCC) is among the most lethal and difficult tumors to treat, particularly when disease has spread beyond the kidney and into the surrounding fascia; even intensive combinations of radio- and chemotherapy are not ..
  25. MDA-7/IL-24 and free radicals in renal cancer therapy
    Paul Dent; Fiscal Year: 2009
    Renal Cell Carcinoma (RCC) is among the most lethal and difficult tumors to treat, particularly when disease has spread beyond the kidney and into the surrounding fascia; even intensive combinations of radio- and chemotherapy are not ..
  26. Autoimmune Mechanisms in the Response to Renal Cancer
    Julie Ellerhorst; Fiscal Year: 2006
    ..on the hypothesis that mechanisms of autoimmunity are utilized to control or kill metastatic renal cell carcinoma (RCC), and that RCC patients who have genotypic or biologic features associated with autoimmune disorders are more ..
  27. Therapeutic Modulation of COX-2-induced Immunosuppression in Metastatic RCC
    Brian Rini; Fiscal Year: 2007
    A previous clinical trial in metastatic renal cell carcinoma (RCC) of interferon alpha (IFNA) combined with a cyclooxygenase-2 (COX-2) inhibitor, celecoxib, demonstrated clinical responses only in patients with tumors expressing high ..
  28. TGF Beta receptor biology in human renal cell carcinoma
    JOHN COPLAND; Fiscal Year: 2009
    Renal cell carcinoma (RCC) is a major health issue. While localized disease can be cured surgically, there is no effective treatment for metastatic disease...
  29. TGF Beta receptor biology in human renal cell carcinoma
    JOHN COPLAND; Fiscal Year: 2007
    Renal cell carcinoma (RCC) is a major health issue. While localized disease can be cured surgically, there is no effective treatment for metastatic disease...
  30. WORKER GENETIC SUSCEPTIBILITY TO MUTAGENIC RISK
    Paul Brandt Rauf; Fiscal Year: 2005
    ..We have also demonstrated a much larger significant effect of an inherited polymorphism in the DNA repair protein XRCC1 on the occurrence of one of these biomarkers (mutant p53), but not the other one (mutant ras-pl 1), in ..
  31. WORKER GENETIC SUSCEPTIBILITY TO MUTAGENIC RISK
    Paul Brandt Rauf; Fiscal Year: 2007
    ..We have also demonstrated a much larger significant effect of an inherited polymorphism in the DNA repair protein XRCC1 on the occurrence of one of these biomarkers (mutant p53), but not the other one (mutant ras-pl1),in ..
  32. BIOPHYSICAL AND SCANNING FORCE MICROSCOPY STUDIES
    DOROTHY ERIE; Fiscal Year: 2001
    ..subsequently sealed by a DNA ligase (either DNA ligase I or DNA ligase III in the presence of the repair protein XRCC1). BER involves a complex set of interactions between the repair proteins and DNA...
  33. Prenatal Exposures & Procarcinogenic Mutations
    Manuela Orjuela; Fiscal Year: 2007
    ..Infant DNA repair capacity (XPD/XRCC1) probably also plays a role in the persistence of chromosomal damage...
  34. New England, New York and Quebec Regional Clinical Center
    Martin LeWinter; Fiscal Year: 2007
    This is an application for designation as a Regional Clinical Center (RCC) of the Heart Failure (HF) Clinical Research Network...
  35. Chemoresistance in Renal Cell Cancer
    JESSIE AU; Fiscal Year: 2006
    Patients with metastatic renal cell cancer (RCC) have a bleak prognosis with an average survival time of less than 18 months. Hence, there is an urgent need of more effective treatments...
  36. Implementation of Resident-Centered Care
    MELANIE KRAUSE; Fiscal Year: 2007
    ..Providing resident-centered care (RCC) is seen by long-term care stakeholders as a promising strategy for achieving higher quality of care and quality of ..
  37. Implementation of Resident-Centered Care
    MELANIE KRAUSE; Fiscal Year: 2009
    ..Providing resident-centered care (RCC) is seen by long-term care stakeholders as a promising strategy for achieving higher quality of care and quality of ..
  38. PROPOSAL TO CREATE A CANADIAN COLLABORATIVE RCC
    Ian Stiell; Fiscal Year: 2007
    This application is a proposal to create a Collaborative Canadian Regional Clinical Center (RCC), with two major partners: the University of Ottawa/OPALS Study Group and the University of British Columbia Group...